期刊文献+

宜昌市HIV/AIDS抗病毒治疗前后CD4^(+)T淋巴细胞变化及影响因素 被引量:7

The changes and influencing factors of CD4^(+)T cell numbers during different periods of antiviral therapy in HIV/AIDS patients in Yichang City
原文传递
导出
摘要 目的分析宜昌市艾滋病感染者/艾滋病患者(HIV/AIDS)开展抗病毒治疗后CD4^(+)T淋巴细胞的变化情况。方法利用国家艾滋病综合防治信息系统-抗病毒治疗管理数据库收集相关信息,分析2003年1月1日至2017年12月31日期间在宜昌开始高效抗逆转录病毒治疗(HAART)并连续治疗满3年的HIV/AIDS CD4^(+)T细胞的变化情况。结果550例HIV/AIDS CD4^(+)T淋巴细胞数在治疗后的3年内各个时间点均有明显上升,并且有随着治疗时间的增加而增长(F=100.20,P<0.001),不同基线水平组的CD4^(+)T细胞计数在治疗前后组间两两比较差异有统计学意义(F=8.57,P<0.01),开始治疗年龄为15~30岁的患者CD4^(+)T淋巴细胞计数上升速度较30岁以上的患者快(F=1.27,P<0.05)。结论HAART对CD4^(+)T上升效果明显,早期治疗效果较好,应全面推进早检测、早诊断、早治疗工作,积极开展抗病毒治疗。 Objective To analyze the changes of CD4^(+)T cell numbers at different periods of antiviral therapy in HIV-infected and AIDS patients(HIV/AIDS)in Yichang City.Methods The relevant information was retrieved from the National AIDS Comprehensive Prevention Information System-Antiretroviral Treatment Management Database.Changes in the number of CD4^(+)T cells were analyzed in HIV/AIDS patients who started receiving highly active antiretroviral therapy(HAART)and continued the treatment for 3 years from January 1,2003 to December 31,2017 in Yichang.Results The number of CD4^(+)T lymphocytes in 550 HIV/AIDS cases increased significantly at various time points within 3 years after treatment,and increased with the increase of treatment time(F=100.20,P<0.001).The CD4^(+)T cell counts of different baseline level groups were statistically different before and after treatment(F=8.57,P<0.01).The CD4^(+)T cell counts of patients who started treatment at age of 15-30 years old increased faster than those who started treatment at age of over 30 years old(F=1.27,P<0.05).Conclusion HAART has a significant effect on the increase of CD4^(+)T cells,and the early treatment is more effective.Early detection,diagnosis and treatment should be promoted,and anti-viral treatment should be actively carried out.
作者 雷雯 刘建华 张慧琦 张皓 杨一 鲁芳芳 田雨 闵洁 李芳芳 陈宏平 LEI Wen;LIU Jian-hua;ZHANG Hui-qi;ZHANG Hao;YANG Yi;LU Fang-fang;TIAN Yu;MIN Jie;LI Fang-fang;CHEN Hong-ping(Yichang Centers for Disease Control and Prevention,Yichang,Hubei 444300,China;Zhijiang Centers for Disease Control and Prevention,Yichang,Hubei 443299,China)
出处 《公共卫生与预防医学》 2021年第6期88-91,共4页 Journal of Public Health and Preventive Medicine
基金 宜昌市医疗卫生研究项目(A20-2-051)。
关键词 HIV/AIDS 高效抗逆转录病毒治疗 CD4^(+)T淋巴细胞 HIV/AIDS HARRT CD4^(+)T cell
  • 相关文献

参考文献15

二级参考文献125

  • 1于兰,豆智慧,曲淑霞,张福杰,文毅,赵燕.HAART药物依从性对CD_4细胞增长率的影响研究[J].中国艾滋病性病,2005,11(4):255-257. 被引量:15
  • 2曹淦,管文辉,吴小刚,胡海洋,施平,还锡萍,羊海涛,汪宁.某同性恋浴室男男性接触者HIV/梅毒感染状况的研究[J].南京医科大学学报(自然科学版),2007,27(6):637-640. 被引量:78
  • 3张福杰,王健,王福生,等.国家免费艾滋病抗病毒药物治疗手册[M].3版.北京:人民卫生出版社,2012:183-185.
  • 4詹思延.流行病学[M].7版.北京:人民卫生出版社,2012.
  • 5张文彤,董伟.SPSS统计分析高级教程[M].2版.北京:高等教育出版社,2013:365-371.
  • 6Yeni P. Update on HAART in HIV [J]. J Hepatol, 2006, 44(1Suppl): S100-S103.
  • 7Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1- infected adults and adolescents. Department of Health and Human Services [EB/OL]. [2014-06-14]. http://aidsinfo.nih. gov/ContentFiles/AdultandAdolescentGL.pdf.
  • 8European AIDS Clinical Society (EACS). EACS Guidelines 7.02 [EB/OL]. [2014-06-14]. http://www.eacsociety.org/ Portals/0/14060 l_EACS%20EN7.02.pdf.
  • 9World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. [EB/OL]. [2014-06-14]. http://www.who.int/iris/bits- tream/10665/85321 / 1/9789241505727_eng.pdf?. ua= 1.
  • 10Persaud D, Gay H, Ziemniak C, et al. Absence of detectable HIV-1 viremia after treatment cessation in an infant [J]. N Engl J Med, 2013, 369(19): 1828-1835.

共引文献208

同被引文献69

引证文献7

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部